For pharmaceutical companies, securing a reliable supply of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates is fundamental to their operations. Deferasirox (CAS: 201530-41-8), a crucial iron chelator, is one such compound. This article explores the perspective of a manufacturer regarding the production and sourcing of Deferasirox, emphasizing the critical factors that ensure its suitability for pharmaceutical use. Understanding the manufacturing process and the supplier's commitment to quality is key for procurement managers and R&D scientists.

As a manufacturer of Deferasirox, our primary focus is on delivering a product that meets the highest industry standards. Deferasirox, with its CAS number 201530-41-8, is synthesized through a rigorous multi-step process. The molecular formula C21H15N3O4 and molecular weight of 373.362 g/mol dictate the specific chemical reactions and purification techniques employed. Achieving a purity level of 97% min is not merely a specification; it is a testament to our advanced manufacturing capabilities and quality assurance protocols. This purity is essential, as Deferasirox is directly used in oral formulations to treat conditions like beta-thalassemia and other anemias characterized by iron overload.

The physical form of Deferasirox—typically a white or pale yellow powder—is also a critical consideration. Consistent particle size and morphology are important for downstream processing, such as tablet compression or suspension formulation. Our manufacturing process is designed to ensure batch-to-batch consistency in these physical attributes, providing predictability for our clients. We understand that as a pharmaceutical intermediate, the physical characteristics of Deferasirox are as important as its chemical purity.

When pharmaceutical companies look to buy Deferasirox, they are not just purchasing a chemical compound; they are investing in the safety and efficacy of their final drug products. This is why selecting a manufacturer with a proven track record is vital. Our commitment extends beyond synthesis to include robust packaging solutions, available in quantities from 25g to bulk, ensuring the integrity of the product during transit and storage. We aim to be a trusted supplier, offering competitive pricing and reliable availability.

The market demands consistent supply and quality. As a manufacturer, we continuously invest in process optimization and analytical testing to uphold the specifications of Deferasirox. This includes ensuring that the melting point (260-262°C) is within the specified range, which serves as an indicator of purity. For R&D scientists exploring new iron chelation therapies or for large-scale production needs, partnering with a dedicated manufacturer like ourselves guarantees access to essential pharmaceutical intermediates. We are committed to supporting the pharmaceutical industry with high-quality Deferasirox, contributing to the advancement of treatments for iron overload disorders.